| Literature DB >> 32669453 |
Sally A M Fenton1,2, Nikos Ntoumanis3, Joan L Duda4, George S Metsios2,5, Peter C Rouse6, Chen-An Yu7, George D Kitas4,2, Jet J C S Veldhuijzen van Zanten4,2.
Abstract
OBJECTIVES: Research demonstrates that sedentary behaviour may contribute towards cardiovascular disease (CVD) risk in rheumatoid arthritis (RA). This study explored diurnal patterns of sedentary time and physical activity (PA) in RA and examined associations with long-term CVD risk.Entities:
Keywords: Cardiovascular disease; arthritis; psychology; rehabilitation; rheumatoid; rheumatoid arthritis
Mesh:
Year: 2020 PMID: 32669453 PMCID: PMC7425187 DOI: 10.1136/rmdopen-2020-001216
Source DB: PubMed Journal: RMD Open ISSN: 2056-5933
Figure 1Extraction of hourly data: illustration of valid-wear criteria for one participant.
Indicates valid hour (ie, 60 min of movement data recorded).
Indicates invalid hour (ie, <60 min of movement data recorded).
Participant characteristics
| Mean ± SD | Range | |
|---|---|---|
| Age (years) | 58 ± 11 | 32–74 |
| Gender (% women) | 69% | |
| Ethnicity (% Caucasian) | 85% | |
| Height (cm) | 166.1 ± 9.2 | 151.0–195.0 |
| Weight (kg) | 77.1 ± 17.1 | 51.0–121.7 |
| RA characteristics | ||
| Disease activity (DAS28) | 3.18 ± 1.75 | 0.00–6.28 |
| Erythrocyte sedimentation rate (mmHrs) | 16.5 ± 15.8 | 2.0–69.0 |
| Functional disability (HAQ) | 1.67 ± 0.56 | 1.00–3.00 |
| Disease duration (years) | 7.2 ± 8.7 | 1–37 |
| Morning stiffness (min/day) | 35 ± 41 | 0–180 |
| Anti-TNF (% yes) | 10% | |
| DMARDS (% yes) | 56% | |
| NSAIDS (% yes) | 29% | |
| Analgesics (% yes) | 24% | |
| Total cholesterol (mmol/L) | 5.0 ± 0.9 | 3.3–6.9 |
| HDL cholesterol (mmol/L) | 1.4 ± 0.4 | 0.8–2.5 |
| Systolic blood pressure (mm Hg) | 136 ± 17 | 99–181 |
| Diastolic blood pressire (mm Hg) | 81 ± 8 | 67–99 |
| BMI (kg/m2) | 27.8±5.5 | 19.7–42.0 |
| Smoker (% current smokers) | 7% | |
| Diabetes (% yes) | 7% | |
| QRISK (%) | 15.8 ± 11.9 | 0.2–48.0 |
| Sedentary time (min/day) | 514.0 ± 65.6 | 350–672 |
| Light-intensity PA (min/day) | 257.9 ± 67.8 | 121–423 |
| Moderate-to-vigorous PA (min/day) | 18.0 ± 17.2 | 0.0–76 |
| Sedentary bout length (≥20 min) (min/bout) | 31.1 ± 2.3 | 27–38 |
| Valid wear time (min/day) | 789.9 ± 41.8 | 698–1467 |
The HAQ typically uses a response scale from 0 (without any difficulty) to 3 (unable to do). In the PARA study, the HAQ was scored on response scale starting at 1 (without any difficulty) to 4 (unable to do).
One participant who did not provide valid daily accelerometer data at baseline (excluded as an outlier) was included in the current secondary analysis, as their hourly data was considered valid. However, this participant was excluded for the purpose producing descriptive statistics to indicate daily estimates of behaviour.
Anti-TNF, anti Tumor Necrosis Factor; BMI, body mass index; CVD, cardiovascular disease risk; DAS28, Disease Activity Score-28; DMARDS, Disease-Modifying Anti-Rheumatic Drugs; HAQ, Health Assessment Questionnaire; HDL, high-density lipoprotein; NSAIDS, non-steroidal anti-inflammatory drugs; PA, physical activity.
Estimated means ± SE for sedentary behaviour and physical activity during the morning, afternoon and evening periods
| Time of day | Sedentary time (min/hour) | Light-intensity PA (min/hour) | Moderate-to-vigorousintensity PA (min/hour) | Sedentary bout length |
|---|---|---|---|---|
| 38.04 ± 1.08 | 20.13 ± 0.98 | 1.86 ± 0.31 | 24.00 ± 1.23 | |
| 39.74 ± 1.01 | 19.21 ± 0.91 | 1.07 ± 0.29* | 26.22 ± 1.24 | |
| 47.80 ± 1.16*,** | 11.97 ± 1.04*,** | 0.25 ± 0.32*,** | 29.30 ± 1.13*,** |
Significantly different from morning, p < .05.
Significantly different from afternoon, p < .05.
Values are min/hour and min/bout (for sedentary bout length). Data represents the estimated mean for a female of average age and average cardiovascular disease risk. PA, physical activity.